Understanding Biological Change
A Single Test Cannot Easily Capture the Full Picture of Change
The body does not exist in a fixed state at a single point in time.
Recovery, inflammation, metabolism, immunity, autonomic activity and cognitive function continue to change over time under the influence of the environment, lifestyle, aging, stress and interventions.
A test at a single point in time provides important information for understanding the condition at that moment.
Understanding changes associated with living conditions and the passage of time also requires comparison across multiple time points and ongoing attention to the direction of change.
ExoEarth adds this time-based perspective to medicine and healthcare, viewing the body as a changing dynamic state space rather than a static point. By connecting ongoing observation, analysis and intervention in a cycle, we aim to deepen understanding of biological changes and inform consideration of next steps.

Scientific Advisory
Connecting with International EV Research

ExoEarth is developing its scientific foundation by incorporating expert knowledge in scientific fields including EV and exosome research.
Takahiro Ochiya, Specially Appointed Professor
Scientific Advisor, ExoEarth
We receive advice on EV and exosome science, research strategy and scientific foundation building from Specially Appointed Professor Takahiro Ochiya, a researcher who has helped lead EV and exosome research, biological communication, and diagnostic and therapeutic applications.
Principal Research Collaborators
ExoEarth pursues research and academic collaboration with Japanese universities in exosome science, extracellular vesicle research and regenerative medicine-related fields.
Tokyo Medical University is proceeding with internal procedures toward establishing an endowed chair.
We are pursuing collaborative research and academic collaboration with Institute of Science Tokyo.
Note: Specific research activities are introduced according to each research plan and the information approved for public disclosure.
RWD and RWE
Since 2019, EXOCURE-related programs at partner medical institutions have recorded approximately 5,000 cumulative uses in private, self-pay medical care.
This figure does not represent unique individuals or the number of people with complete longitudinal data for the same measures. It does not demonstrate any particular efficacy or safety. Medical records are managed by each medical institution.
Data obtained in real-world medical care and health support settings are referred to as Real World Data (RWD).
Unlike data collected under standardized research conditions, they include information from diverse individuals whose ages, lifestyles, health conditions and activities differ.
ExoEarth is organizing data available through the necessary procedures and developing an analytics infrastructure for future scientific validation.
Note: Approximately 5,000 refers to cumulative uses of EXOCURE programs at partner medical institutions since 2019, including repeated use by the same individual. It does not mean longitudinal data from approximately 5,000 people or evidence of efficacy or safety. Records are held by each medical institution.
Note: This diagram illustrates an approach to data use. Analytics infrastructure is under development, and AI applications remain an R&D concept. It does not indicate automatic data integration or medical decision-making by AI. Medical decisions are made by physicians at partner medical institutions.
Data Organization and Analytics Infrastructure
EXOCURE AI is an ExoEarth research and development concept. We are currently organizing available data and developing an analytics infrastructure.
It is not offered as a system for diagnosis or determining treatment plans. Medical decisions are made by physicians at partner medical institutions.
In the future, we aim to use data accumulated and organized over time to understand biological changes and support scientific validation.
Academic Collaboration
ExoEarth pursues collaboration with academic foundations across exosome research, regenerative medicine and biological analysis.
We also work with networks of medical institutions, universities, researchers and other specialists to develop an analytics infrastructure for real-world and longitudinal observation data.
We aim to connect available real-world data with scientific knowledge from collaborative research with universities and other institutions, supporting understanding of ongoing biological changes and future scientific validation.
Note: Approximately 5,000 refers to cumulative uses of EXOCURE programs at partner medical institutions since 2019, including repeated use by the same individual. It does not mean longitudinal data from approximately 5,000 people or evidence of efficacy or safety. Records are held by each medical institution.
Note: This diagram illustrates an approach to data use. Analytics infrastructure is under development, and AI applications remain an R&D concept. It does not indicate automatic data integration or medical decision-making by AI. Medical decisions are made by physicians at partner medical institutions.
Science for Healthy Longevity
ExoEarth does not believe Healthy Longevity can be achieved through a single procedure or a particular substance alone.
We aim to deepen understanding of the body and continually review activities by observing changes over time, recording and organizing them, and incorporating them into subsequent considerations.
ExoEarth is developing a cycle of observation, recording, organization and review as a scientific foundation connecting real-world data, R&D, academic research and clinical intervention, building a foundation toward Healthy Longevity.

